CD160 and B-cell chronic lymphocytic leukemia: This assay was validated against previously published data utilizing the CD160 flow cytometric assay (CD160FCA) (18, 19) and the single tube 8-color panel designed by the ERIC group, considered as the original “gold standard” for CLL MRD detection (41, 42).